Furthermore, 104 patients (28%) have a New York Heart Association (NYHA) class III/IV, 165 (48%) have a history of CAD, and the median NT-proBNP level is 1237 pg/mL [Q1 458; Q3 2463] (Supplementary Data 4). Here, NPPB is linked to coronary artery disorder.